Home > Boards > US OTC > Cannabis > Acology, Inc. (ACOL)

CORONA, Calif., Sept. 27, 2017 (GLOBE NEWSWIRE) --

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Munoz Enterprise Member Profile
Followed By 5
Posts 215
Boards Moderated 0
Alias Born 11/03/16
160x600 placeholder
Munoz Enterprise   Thursday, 09/28/17 10:31:01 PM
Re: None
Post # of 18381 
CORONA, Calif., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Acology Inc. (OTC:ACOL) announced today that they have taken delivery of 200,000 pieces of their newly labeled and improved 2-way humidity system from Desiccare Inc. MedX humidity packets are now being delivered to Acology’s more than 4,000 distributors worldwide. Further, Acology has begun to deliver each manufactured and sold Medtainer™ with a sealed 4gr humidity packet. This packet can be activated by the consumer once the sealed plastic envelope is removed. Extensive studies conducted by Desiccare Inc. have proven that the new MedX humidity systems will keep plants and plant material fresher while maintaining perfect aroma and color.

Desiccare released its own statement about the association last week in which President and CEO Ken Blakenhorn said, “Quality is our basic principle,” and quoted Acology CEO Curt Fairbrother, “We’re very pleased with the way Desiccare stepped up and saw the possibilities that a partnership would offer.” This action comes only two weeks after Acology announced its deal with Desiccare Inc. to produce and sell 2-way humidity control packets using Acology’s MedX brand. It is anticipated that several more business associations will be reached in the near future. Ideal partners would complement Acology’s global reach and give the new product line added emphasis in the growing cannabis plant and edibles market.

This expansion is a continuation of Acology’s aggressive program, announced at the beginning of the year and rapidly continuing through the end of the quarter, of reaching into new spaces in the medical and recreational cannabis industry. The retiring of the third-party conversion note, announced 3 weeks ago, has enabled Acology to accelerate this planned expansion and has drawn the interest of other potential business partners. Strategic moves, such as the partnership deal with Desiccare Inc., changing Acology’s OTC status, placing new emphasis on the traditional medical industry and concluding additional partnership agreements with one or more prominent national and multi-national businesses are now the next steps in this expansion.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist